Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Net of Acquisitions & Divestments (2023 - 2025)

Updated

Analysis

Regeneron Pharmaceuticals (REGN) Net of Acquisitions & Divestments (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 17.24 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 39.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -11.21 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -300,000.00
Sep 30, 2025 -3.00 Mn
Dec 31, 2024 -11.50 Mn
Dec 31, 2023 -3.80 Mn
Sep 30, 2023 -51.10 Mn
API Access

Regeneron Pharmaceuticals Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=REGN&period=max&api_key=YOUR_API_KEY